Skip to main content
BIO KEY INTERNATIONAL INC logo

BIO KEY INTERNATIONAL INC — Investor Relations & Filings

Ticker · BKYI ISIN · US09060C3097 LEI · 549300VFT6WAQB4BVB07 US Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 1,005 across all filing types
Latest filing 2024-05-16 Regulatory Filings
Country US United States of America
Listing US BKYI

About BIO KEY INTERNATIONAL INC

https://www.bio-key.com/

BIO KEY INTERNATIONAL INC is a provider of Identity and Access Management (IAM) and biometric identity solutions. The company develops technologies aimed at creating a secure, passwordless, and phishing-resistant environment for users. Its core offering is the PortalGuard platform, an IAM and Identity-as-a-Service (IDaaS) solution that provides multi-factor authentication (MFA), single sign-on (SSO), and self-service password reset capabilities. A key differentiator is its proprietary Identity-Bound Biometrics, particularly fingerprint identification technology, which is designed for rapid and accurate user verification. BIO-key offers flexible deployment options, including SaaS, hybrid, and on-premises, to support various organizational security strategies such as cloud migration and securing remote workforces.

Recent filings

Filing Released Lang Actions
FORM NT 10-Q
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing with the SEC. It specifically states that the company, BIO-key International, Inc., is unable to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2024, due to the need to restate prior financial statements. The document does not contain the actual financial statements or substantive financial data but is a notification explaining the delay and the reasons behind it. According to the rules, such a notification is a Regulatory Filing (RNS) because it is a compliance document notifying the SEC and investors about the late filing and related circumstances, not the report itself.
2024-05-16 English
FORM 8-K
Audit Report / Information Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated April 23, 2024, reporting a change in the company's independent registered public accounting firm. It details the dismissal of Marcum LLP and the engagement of Bush & Associates CPA as the new auditor. The report discusses prior audit opinions, disagreements, and reportable events related to the audits but does not contain any financial statements or substantive financial data itself. It also includes a letter from the former auditor as an exhibit. This type of filing is specifically about changes in the auditor and related disclosures, which fits the category of Audit Report / Information (AR) rather than a full Annual Report or other financial report. The document length (7,564 characters) and content confirm it is a standalone audit-related report rather than an announcement or certification only. Therefore, the correct classification is AR with high confidence.
2024-04-29 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by BIO-key International, Inc. It primarily discloses a notice of delisting due to failure to timely file the Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and details about non-reliance on previously issued financial statements due to errors requiring restatement. The document includes regulatory disclosures about Nasdaq compliance and audit committee findings but does not contain the actual financial statements or the full Annual Report itself. It also references a press release attached as an exhibit. The document is a regulatory announcement about financial reporting issues and Nasdaq compliance, not the Annual Report or audit report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance disclosure.
2024-04-22 English
FORM NT 10-K
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the company, BIO-key International, Inc., is unable to timely file its Annual Report on Form 10-K for the year ended December 31, 2023, and expects to file it within 15 days after the due date. The document includes a narrative explaining the delay and some preliminary financial information, but it is not the actual 10-K report itself. The document is short and serves as a notification rather than the full annual report. According to the rules, such a notification is classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the delay in filing the 10-K, not the 10-K report itself.
2024-04-02 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 1, 2024, reporting the issuance of a press release announcing financial results for the fourth quarter and year ended December 31, 2023. The text explicitly states that the press release is attached as Exhibit 99.1 and that the Form 8-K itself is a current report, not the full earnings release. The document length is 3466 characters, which is relatively short and mainly serves as an announcement of the earnings release rather than containing the full financial results. According to the 'Menu vs Meal' rule, this is an announcement of a report (the earnings release) rather than the report itself. Therefore, the correct classification is Earnings Release (ER), as the press release attached is the initial announcement of quarterly/year-end financial results.
2024-04-02 English
FORM 4
Director's Dealing
2024-03-29 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.